Ra Capital Management, L.p.

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
85
Total Value
5952606666
Accession Number
0001104659-25-049549
Form Type
13F-HR
CIK
0001346824
Manager Name
Ra Capital Management, L.p.
Data Enrichment
91% identified
77 identified8 unidentified

Holdings

85 positions
Manager:
SEC
Search and click to pin securities to the top
Page 1 of 5
Ascendis Pharma A/S
ASND|04351P101
Shares:
10281496(+1.7%)
Value:
$1.6T(+15.1%)
Vaxcyte, Inc.
PCVX|92243G108
Shares:
12189149(+40.3%)
Value:
$460.3B(-35.3%)
RHYTHM PHARMACEUTICALS, INC.
RYTM|76243J105
Shares:
6084412(+0.0%)
Value:
$322.3B(-5.4%)
Janux Therapeutics, Inc.
JANX|47103J105
Shares:
11189693(+7.9%)
Value:
$302.1B(-45.6%)
NewAmsterdam Pharma Co N.V.
NAMS|N62509109
Shares:
10138938(+14.6%)
Value:
$207.5B(-8.7%)
Arcellx, Inc.
ACLX|03940C100
Shares:
3036527(+8.9%)
Value:
$199.2B(-6.8%)
Edgewise Therapeutics, Inc.
EWTX|28036F105
Shares:
8909091(+0.0%)
Value:
$196.0B(-17.6%)
Avidity Biosciences, Inc.
RNA|05370A108
Shares:
6300408(+0.0%)
Value:
$186.0B(+1.5%)
Wave Life Sciences Ltd.
WVE|Y95308105
Shares:
18202009(+0.0%)
Value:
$147.1B(-34.7%)
89bio, Inc.
ETNB|282559103
Shares:
19889683(+40.3%)
Value:
$144.6B(+30.4%)
ARS Pharmaceuticals, Inc.
SPRY|82835W108
Shares:
10860977(+0.0%)
Value:
$136.6B(+19.2%)
829401108
829401108
Shares:
10445322
Value:
$109.3B
LENZ Therapeutics, Inc.
LENZ|52635N103
Shares:
4178823(+0.0%)
Value:
$107.4B(-10.9%)
Dyne Therapeutics, Inc.
DYN|26818M108
Shares:
9714392(+52.2%)
Value:
$101.6B(-32.4%)
Tyra Biosciences, Inc.
TYRA|90240B106
Shares:
10637290(+0.0%)
Value:
$98.9B(-33.1%)
Mineralys Therapeutics, Inc.
MLYS|603170101
Shares:
6147280(+26.7%)
Value:
$97.6B(+63.5%)
GERON CORP
GERN|374163103
Shares:
60379366(+101.2%)
Value:
$96.0B(-9.6%)
RxSight, Inc.
RXST|78349D107
Shares:
3743018(+0.0%)
Value:
$94.5B(-26.6%)
Bicara Therapeutics Inc.
BCAX|055477103
Shares:
6955993(+0.0%)
Value:
$90.6B(-25.2%)
Disc Medicine, Inc.
IRON|254604101
Shares:
1577106
Value:
$78.3B